John F. Neylan
Equibles does not estimate personal net worth.
About John F. Neylan
The proxy statement of Elicio Therapeutics, Inc. reports total compensation of $1,232,513 for John F. Neylan in fiscal 2021, including a base salary of $468,650.
Affiliation history
-
Elicio Therapeutics, Inc. (ELTX)
Proxy statement
Start not stated–2022-04-27
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Elicio Therapeutics, Inc. (ELTX) | M.D., Executive Vice President, Chief Medical Officer and Head of Research | $468,650 | $1,232,513 |
Recent activity
No call appearances or filed executive changes recorded yet.